Hologic Inc (HOLX) - Total Assets

Latest as of December 2025: $9.18 Billion USD

Based on the latest financial reports, Hologic Inc (HOLX) holds total assets worth $9.18 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Hologic Inc book value and equity for net asset value and shareholders' equity analysis.

Hologic Inc - Total Assets Trend (1989–2025)

This chart illustrates how Hologic Inc's total assets have evolved over time, based on quarterly financial data.

Hologic Inc - Asset Composition Analysis

Current Asset Composition (September 2025)

Hologic Inc's total assets of $9.18 Billion consist of 40.7% current assets and 59.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 21.7%
Accounts Receivable $600.80 Million 6.7%
Inventory $679.40 Million 7.5%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $589.10 Million 6.5%
Goodwill $3.64 Billion 40.4%

Asset Composition Trend (1989–2025)

This chart illustrates how Hologic Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Hologic Inc stock valuation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Hologic Inc's current assets represent 40.7% of total assets in 2025, a decrease from 94.4% in 1989.
  • Cash Position: Cash and equivalents constituted 21.7% of total assets in 2025, down from 37.0% in 1989.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 0.0% in 1989.
  • Asset Diversification: The largest asset category is goodwill at 40.4% of total assets.

Hologic Inc Competitors by Total Assets

Key competitors of Hologic Inc based on total assets are shown below.

Company Country Total Assets
Visco Vision Inc.
TW:6782
Taiwan NT$5.82 Billion
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
China CN¥1.75 Billion
Osteopore Ltd
AU:OSX
Australia AU$4.19 Million
MEDIMI AB AK
F:79T
Germany €1.70 Million
Ansell Ltd
AU:ANN
Australia AU$3.32 Billion
Nanosonics Ltd
AU:NAN
Australia AU$272.48 Million
SDI Ltd
AU:SDI
Australia AU$141.20 Million
Austco Healthcare Ltd
AU:AHC
Australia AU$91.07 Million

Hologic Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.04 3.49 2.57
Quick Ratio 3.32 2.78 2.13
Cash Ratio 0.00 0.00 0.00
Working Capital $2.89 Billion $2.49 Billion $1.63 Billion

Hologic Inc - Advanced Valuation Insights

This section examines the relationship between Hologic Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.20
Latest Market Cap to Assets Ratio 1.86
Asset Growth Rate (YoY) -1.5%
Total Assets $9.01 Billion
Market Capitalization $16.77 Billion USD

Valuation Analysis

Above Book Valuation: The market values Hologic Inc's assets above their book value (1.86x), reflecting positive investor sentiment about the company's future prospects.

Slight Asset Contraction: Hologic Inc's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Hologic Inc (1989–2025)

The table below shows the annual total assets of Hologic Inc from 1989 to 2025.

Year Total Assets Change
2025-09-30 $9.01 Billion -1.54%
2024-09-30 $9.16 Billion +0.18%
2023-09-30 $9.14 Billion +0.75%
2022-09-30 $9.07 Billion +1.70%
2021-09-30 $8.92 Billion +23.96%
2020-09-30 $7.20 Billion +8.84%
2019-09-30 $6.61 Billion -8.57%
2018-09-30 $7.23 Billion -9.38%
2017-09-30 $7.98 Billion +9.06%
2016-09-30 $7.32 Billion -4.60%
2015-09-30 $7.67 Billion -8.85%
2014-09-30 $8.41 Billion -6.51%
2013-09-30 $9.00 Billion -14.09%
2012-09-30 $10.48 Billion +74.36%
2011-09-30 $6.01 Billion +6.81%
2010-09-30 $5.63 Billion -1.12%
2009-09-30 $5.69 Billion -30.05%
2008-09-30 $8.13 Billion +662.85%
2007-09-30 $1.07 Billion +24.54%
2006-09-30 $856.21 Million +205.96%
2005-09-30 $279.84 Million +32.15%
2004-09-30 $211.75 Million +12.27%
2003-09-30 $188.60 Million +2.35%
2002-09-30 $184.28 Million -5.56%
2001-09-30 $195.12 Million -11.17%
2000-09-30 $219.66 Million +24.95%
1999-09-30 $175.80 Million +1.85%
1998-09-30 $172.60 Million +19.28%
1997-09-30 $144.70 Million +17.55%
1996-09-30 $123.10 Million +263.13%
1995-09-30 $33.90 Million +18.95%
1994-09-30 $28.50 Million +28.38%
1993-09-30 $22.20 Million -2.20%
1992-09-30 $22.70 Million +14.65%
1991-09-30 $19.80 Million -2.46%
1990-09-30 $20.30 Million +275.93%
1989-09-30 $5.40 Million --

About Hologic Inc

NASDAQ:HOLX USA Medical Instruments & Supplies
Market Cap
$16.97 Billion
Market Cap Rank
#1488 Global
#568 in USA
Share Price
$76.01
Change (1 day)
+0.48%
52-Week Range
$54.28 - $76.01
All Time High
$87.67
About

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms… Read more